Medipoint Hospitals Pvt. Ltd.

Pune 411007

3 studies enrolling now · 6 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chronic Migraine, Episodic Migraine, Rheumatoid Arthritis, Schizophrenia, Ulcerative Colitis

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: — Recruiting now
• A Study of Brenipatide in Adult Participants With Schizophrenia — Recruiting now
• An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis — Completed
• A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine — Running, not enrolling
• A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine — Running, not enrolling